Prevention and treatment of ocular side effects with a cyclosporin
AssigneeAllergan, Inc.
InventorsGregg Feinerman, Neil Barth, Rhett Schiffman, Pamela Barnett
Life of this patent
Estimating the term…
Abstract
Therapeutic methods are disclosed herein.
Claims20
A method comprising administering a cyclosporin, an analog or derivative thereof or a combination thereof to an eye of a mammal in combination with administration of a therapeutically active agent to said mammal, said therapeutically active agent being a chemotherapy agent, an antiviral agent or an immunomodulator, wherein said method is effective in treating an ocular condition associated with the use of said therapeutically active agent.
A method comprising administering cyclosporin A topically to the eye of a person, wherein docetaxel is also administered to said person, wherein said method is effective in treating an ocular condition associated with the administration of docetaxel.
Dependencies are inferred from the claim text.